Drug
LU Af35700 Clinical Formulation
LU Af35700 Clinical Formulation: highest development phase Phase 1, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lu AF35700 5 mg clinical formulation NCT03394482 | Phase 1 | Healthy |
Latest
No recent events.
Follow LU Af35700 Clinical Formulation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.